What is the most effective oral prophylactic medication for cluster headache?

Best Oral Medicine for Cluster Headache Prophylaxis

Verapamil is the first-line oral prophylactic medication for cluster headache, with a recommended starting dose of at least 240 mg daily, titrated upward based on efficacy and tolerability. 1, 2, 3

Primary Prophylactic Agent

• Verapamil (calcium channel blocker) is the drug of choice for preventing cluster headache attacks in both episodic and chronic forms, though the evidence quality remains limited. 2, 4, 5

• The effective daily dose is at least 240 mg, with maximum dosing determined by individual efficacy and tolerability—many patients require 360-480 mg daily or higher. 2, 4

• Mandatory cardiac monitoring with electrocardiogram (ECG) is required before initiating verapamil and periodically during dose escalation due to risk of cardiac arrhythmias, particularly heart block. 4, 5, 6

• The therapeutic effect may take several weeks to manifest, necessitating bridging therapy during the titration period. 4, 5

Second-Line Oral Options

• Lithium carbonate is recommended as an alternative prophylactic agent when verapamil is contraindicated, ineffective, or not tolerated. 2, 4, 6

• Lithium requires monitoring of liver and kidney function before and during treatment due to potential toxicity. 4

• Topiramate is recommended as a second-choice option after verapamil and lithium failure or contraindication. 2, 4, 6

• Galcanezumab (300 mg subcutaneous injection) is recommended specifically for episodic cluster headache prophylaxis but is not recommended for chronic cluster headache. 1, 2, 4

Bridging/Transitional Therapy

• Oral corticosteroids (prednisone at least 100 mg daily or equivalent) are recommended as transitional prophylaxis to control attacks while waiting for verapamil to reach therapeutic effect. 2, 4, 5

• The corticosteroid course should be given over approximately 5 days, with efficacy demonstrated at doses up to 500 mg IV daily. 2

• Greater occipital nerve block is the most proven transitional treatment option as an alternative to corticosteroids. 2, 4

Important Clinical Caveats

• There is insufficient evidence to recommend for or against verapamil specifically in the 2024 VA/DoD guidelines, highlighting the ongoing need for higher-quality trials despite widespread clinical use. 1

• Emerging evidence suggests atogepant (60 mg daily oral CGRP antagonist) may be effective for cluster headache prophylaxis, including in cases refractory to galcanezumab, though this is based on case series only. 7

• Other agents with lower levels of evidence include melatonin, gabapentin, divalproex sodium, and baclofen—these should be considered only after failure of first- and second-line options. 3, 4

• The primary goal of prophylactic treatment is complete attack freedom, though this is not always achievable. 4

Monitoring Algorithm

1. Obtain baseline ECG before starting verapamil 4, 5
2. Initiate verapamil at 240 mg daily with concurrent bridging therapy (prednisone or nerve block) 2, 4
3. Repeat ECG with each dose escalation 5
4. Titrate verapamil every 1-2 weeks until attack freedom or limiting side effects 4
5. If verapamil fails at maximum tolerated dose, switch to lithium with appropriate laboratory monitoring 4, 6
6. Consider topiramate as third-line option 2, 4